McKesson Corporation (N:MCK)

Sector:  Consumer Non-Cyclicals Industry:  Drug Retailers
See Regulatory Filings on SEC
Company Contact
Address: 6555 State Highway 161
IRVING TX 75039-2402
Tel: N/A
IR: See website
Key People
Edward A. Mueller
Independent Chairman of the Board
Brian Scott Tyler
Chief Executive Officer, Director
Britt J. Vitalone
Chief Financial Officer, Executive Vice President
Tracy Faber
Chief Human Resource Officer, Executive Vice President
Nancy Flores
Executive Vice President, Chief Technology Officer, Chief Information Officer
Lori Ann Schechter
Executive Vice President, Chief Compliance Officer, General Counsel
Tom Rodgers
Executive Vice President and Chief Strategy and Business Development Officer
Business Overview
McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.
Financial Overview
For the three months ended 30 June 2020, McKesson Corporation revenues decreased less than 1% to $55.68B. Net income before extraordinary items increased 4% to $445M. Revenues reflect U.S. Pharmaceutical and Specialty Solutions segment increase of 2% to $45.06B, United States segment increase of 2% to $47.13B, also reflect European Pharmaceutical Solutions segment decrease of 7% to $6.25B, Other segment decrease of 13% to $2.57B.
Employees: 80,000 as of Mar 31, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $28,606M as of Jun 30, 2020
Annual revenue (TTM): $231,002M as of Jun 30, 2020
EBITDA (TTM): $3,957M as of Jun 30, 2020
Net annual income (TTM): $922.00M as of Jun 30, 2020
Free cash flow (TTM): $2,558M as of Jun 30, 2020
Net Debt Last Fiscal Year: $4,835M as of Jun 30, 2020
Shares outstanding: 162,189,761 as of Jun 30, 2020
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.